Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies.
Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies.
复制标题
DOI:
10.1016/j.nicl.2015.01.017
复制
发表时间:
2015
影响因子:
4.2
通讯作者:
OBrien, John T.
中科院分区:
文献类型:
--
作者:
Mak, Elijah;Su, Li;Williams, Guy B.;Watson, Rosie;Firbank, Michael;Blamire, Andrew M.;OBrien, John T.
Percent whole brain volume change (PBVC) measured from serial MRI scans is widely accepted as a sensitive marker of disease progression in Alzheimer's disease (AD). However, the utility of PBVC in the differential diagnosis of dementia remains to be established. We compared PBVC in AD and dementia with Lewy bodies (DLB), and investigated associations with clinical measures. 72 participants (14 DLBs, 25 ADs, and 33 healthy controls (HCs)) underwent clinical assessment and 3 Tesla T1-weighted MRI at baseline and repeated at 12 months. We used FSL-SIENA to estimate PBVC for each subject. Voxelwise analyses and ANCOVA compared PBVC between DLB and AD, while correlational tests examined associations of PBVC with clinical measures. AD had significantly greater atrophy over 1 year (1.8%) compared to DLB (1.0%; p = 0.01) and HC (0.9%; p < 0.01) in widespread regions of the brain including periventricular areas. PBVC was not significantly different between DLB and HC (p = 0.95). There were no differences in cognitive decline between DLB and AD. In the combined dementia group (AD and DLB), younger age was associated with higher atrophy rates (r = 0.49, p < 0.01). AD showed a faster rate of global brain atrophy compared to DLB, which had similar rates of atrophy to HC. Among dementia subjects, younger age was associated with accelerated atrophy, reflecting more aggressive disease in younger people. PBVC could aid in differentiating between DLB and AD, however its utility as an outcome marker in DLB is limited. AD showed faster global and regional brain atrophy in comparison to DLB. Similar rates of global and regional atrophy were found in DLB and HC. Longitudinal imaging could improve clinical differentiation of DLB from AD. Atrophy rates might not be a useful marker to track disease progression in DLB.
登录
查看更多内容
DOI:
10.1523/jneurosci.3252-09.2009
发表时间:
2009-12-02
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Fjell AM;Walhovd KB;Fennema-Notestine C;McEvoy LK;Hagler DJ;Holland D;Brewer JB;Dale AM
通讯作者:
Dale AM
影响因子:
38.1
作者:
Frisoni, Giovanni B.;Fox, Nick C.;Jack, Clifford R., Jr.;Scheltens, Philip;Thompson, Paul M.
通讯作者:
Thompson, Paul M.
影响因子:
6
作者:
Nelson PT;Schmitt FA;Jicha GA;Kryscio RJ;Abner EL;Smith CD;Van Eldik LJ;Markesbery WR
通讯作者:
Markesbery WR
影响因子:
168.9
作者:
Fox, NC;Crum, WR;Rossor, MN
通讯作者:
Rossor, MN
影响因子:
2.6
作者:
Marshall, Gad A.;Fairbanks, Lynn A.;Cummings, Jeffrey L.
通讯作者:
Cummings, Jeffrey L.